Steward Partners Investment Advisory, LLC Mirum Pharmaceuticals, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $10.9 Billion
- Q1 2025
A detailed history of Steward Partners Investment Advisory, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 2,050 shares of MIRM stock, worth $92,824. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,050
Previous 2,800
26.79%
Holding current value
$92,824
Previous $115,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding MIRM
# of Institutions
227Shares Held
55MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$308 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$216 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$147 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$127 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$115 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.66B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...